Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The lower risk MDS patient at risk of rapid progression.

Leukemia research - 1 Dec 2010

Mittelman Moshe, Oster Howard S, Hoffman Michael, Neumann Drorit

Abstract excerpt

Most patients with myelodysplastic syndrome (MDS) are classified at diagnosis as having a low/INT-I or INT-II/high risk disease, based on the classical International Prognostic Scoring System (IPSS) criteria. The low/INT-I risk patients are usually managed mildly with supportive care, including red blood cell (RBC) transfusions, erythroid stimulating agents (ESAs), other cytokines (G-CSF, platelet stimulating...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Survivin
Share to Thalidomide
Share to Lymphoid Enhancer-Binding Factor 1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to alpha Catenin

Share to Axl Receptor Tyrosine Kinase

Share to Cyclin-Dependent Kinase Inhibitor p15

Share to Erythrocyte Transfusion

Share to Lenalidomide

Source

Identifiers

PMID: 20573398
DOI: 10.1016/j.leukres.2010.05.023

Genes

ASXL1
CTNNA1
TET2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The lower risk MDS patient at risk of rapid progression.PMID 20573398Read ↗

How I treat higher-risk MDSSemantic proximity Read ↗

Critical Role of Molecular-Based Stratification in Low-Risk Myelodysplastic Syndrome with Direct Progression to Acute Myeloid Leukemia: A Case Report.Semantic proximity Read ↗

Patterns of lower risk myelodysplastic syndrome progression: factors predicting progression to high-risk myelodysplastic syndrome and acute myeloid leukemia.Semantic proximity Read ↗

Therapy for lower-risk MDS.Semantic proximity Read ↗

Incorporation mutational profile might reduce the importance of blast count in prognostication of low-risk myelodysplastic syndromes.Semantic proximity Read ↗

Mutation status and burden can improve prognostic prediction of patients with lower-risk myelodysplastic syndromes.Semantic proximity Read ↗

Excellent Prognosis of Low-Risk Myelodysplastic Syndromes (MDS) Without Detectable Myeloid-Related Mutations.Semantic proximity Read ↗

RUNX1 mutations contribute to the progression of MDS due to disruption of antitumor cellular defense: a study on patients with lower-risk MDS.Semantic proximity Read ↗

Asian Population Is More Prone to Develop High-Risk Myelodysplastic Syndrome, Concordantly with Their Propensity to Exhibit High-Risk Cytogenetic AberrationsSemantic proximity Read ↗

Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndromeSemantic proximity Read ↗

Prognostic Significance of Low Serum Apolipoprotein A1 Levels at Diagnosis are Independent Prognostic Factors in De Novo Myelodysplastic Syndrome, and with Higher Frequency of TP53 MutationSemantic proximity Read ↗

There's risk, and then there's risk: The latest clinical prognostic risk stratification models in myelodysplastic syndromes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.